178 related articles for article (PubMed ID: 17593306)
1. The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study.
Clements A; Watson E; Rai T; Bukach C; Shine B; Austoker J
BMC Fam Pract; 2007 Jun; 8():35. PubMed ID: 17593306
[TBL] [Abstract][Full Text] [Related]
2. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
[TBL] [Abstract][Full Text] [Related]
3. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
Pickles K; Carter SM; Rychetnik L
BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
[TBL] [Abstract][Full Text] [Related]
4. Primary goals, information-giving and men's understanding: a qualitative study of Australian and UK doctors' varied communication about PSA screening.
Pickles K; Carter SM; Rychetnik L; McCaffery K; Entwistle VA
BMJ Open; 2018 Jan; 8(1):e018009. PubMed ID: 29362252
[TBL] [Abstract][Full Text] [Related]
5. Factors prompting PSA-testing of asymptomatic men in a country with no guidelines: a national survey of general practitioners.
Drummond FJ; Carsin AE; Sharp L; Comber H
BMC Fam Pract; 2009 Jan; 10():3. PubMed ID: 19138385
[TBL] [Abstract][Full Text] [Related]
6. [Early detection of prostate cancer by PSA testing: the results of a qualitative study on barriers caused by physicians in Austria implementing informed decision making].
Malli G
Gesundheitswesen; 2013 Jan; 75(1):22-8. PubMed ID: 22836936
[TBL] [Abstract][Full Text] [Related]
7. GPs views and understanding of PSA testing, screening and early detection; survey.
Sutton J; Melia J; Kirby M; Graffy J; Moss S
Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
[TBL] [Abstract][Full Text] [Related]
8. Doctors' perspectives on PSA testing illuminate established differences in prostate cancer screening rates between Australia and the UK: a qualitative study.
Pickles K; Carter SM; Rychetnik L; Entwistle VA
BMJ Open; 2016 Dec; 6(12):e011932. PubMed ID: 27920082
[TBL] [Abstract][Full Text] [Related]
9. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen testing among the elderly in community-based family medicine practices.
Hudson SV; Ohman-Strickland P; Ferrante JM; Lu-Yao G; Orzano AJ; Crabtree BF
J Am Board Fam Med; 2009; 22(3):257-65. PubMed ID: 19429731
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen testing rates and referral patterns from general practice data in England.
Moss S; Melia J; Sutton J; Mathews C; Kirby M
Int J Clin Pract; 2016 Apr; 70(4):312-8. PubMed ID: 26987766
[TBL] [Abstract][Full Text] [Related]
12. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
[TBL] [Abstract][Full Text] [Related]
13. Association of GPs' risk attitudes, level of empathy, and burnout status with PSA testing in primary care.
Pedersen AF; Carlsen AH; Vedsted P
Br J Gen Pract; 2015 Dec; 65(641):e845-51. PubMed ID: 26541183
[TBL] [Abstract][Full Text] [Related]
14. GP and patient predictors of PSA screening in Australian general practice.
Gattellari M; Young JM; Ward JE
Fam Pract; 2003 Jun; 20(3):294-303. PubMed ID: 12738699
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
[TBL] [Abstract][Full Text] [Related]
16. Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study.
Melia J; Moss S; Johns L;
BJU Int; 2004 Jul; 94(1):51-6. PubMed ID: 15217430
[TBL] [Abstract][Full Text] [Related]
17. PSA testing for men at average risk of prostate cancer.
Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
[TBL] [Abstract][Full Text] [Related]
18. General Practitioners' Experiences of, and Responses to, Uncertainty in Prostate Cancer Screening: Insights from a Qualitative Study.
Pickles K; Carter SM; Rychetnik L; McCaffery K; Entwistle VA
PLoS One; 2016; 11(4):e0153299. PubMed ID: 27100402
[TBL] [Abstract][Full Text] [Related]
19. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study.
Guerra CE; Jacobs SE; Holmes JH; Shea JA
J Gen Intern Med; 2007 Jul; 22(7):901-7. PubMed ID: 17549576
[TBL] [Abstract][Full Text] [Related]
20. Urological referral of asymptomatic men in general practice in England.
Melia J; Coulson P; Coleman D; Moss S
Br J Cancer; 2008 Apr; 98(7):1176-81. PubMed ID: 18349841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
